AURA logo

AURA Aura Biosciences, Inc.

NASDAQ Global Market · Biotechnology · Healthcare

$7.11
+0.00 (+0.00%)

Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary virus-like drug conjugate (VDC) technology platform to address tumors with significant unmet medical needs, specifically in ocular (eye) and urologic oncology. Its flagship therapeutic candidate, AU-011…

Market Cap: $739.97Mwww.aurabiosciences.com

Price

No data yet.

Social Signal Score

45
5d
—
30d
43
4 mentions
—
60d
43
4 mentions
—
90d
48
6 mentions
—
news: 6

Analyst Ratings

8 analysts
Buyconsensus
Strong Buy 0Buy 8Hold 0Sell 0Strong Sell 0
Avg price target$16.5+132.1%
Low $15Median $16.5High $18
Current Consensus

Revenue

$0.00
$0.00
Mar 2020Sep 2026

Analyst Estimates

FY2025
$-1.96
$-1.98–$-1.94
4 analysts
FY2026
$-1.51
$-1.53–$-1.48
3 analysts
FY2027
$-1.25
$-1.31–$-1.18
3 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Natalie C. Holles
Sector
Healthcare
Industry
Biotechnology
Employees
113
Beta
0.41
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
10.00
www.aurabiosciences.com